Advertisement

Hormonal Contraceptive Use May Delay Return of Fecundability

0

Longest delay of five to eight months found for users of injectable contraceptives; no lasting effect seen on fecundability for long-term use

Triplet Therapy Slows Refractory Multiple Myeloma

0

Progression-free survival longer with once-weekly selinexor-containing regimen versus standard bortezomib and dexamethasone

HealthDay Reports: Brazil

FDA Approves First Rapid COVID-19 Test for Home Use

0

Simple nasal swab test requires prescription; people younger than 14 cannot perform the test on themselves

ctm -- B 11/4 Not All Pediatric Heart Tests Are Necessary

Antibiotic Therapy Before Age 2 May Affect Child Health

0

Risk for childhood onset of health conditions increased for those with early-life antibiotic exposure

HealthDay Reports: Coronavirus Has Killed Thousands at US Nursing Homes

Nebulized Interferon Beta-1a Promising for COVID-19

0

Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement

Female Hormone Rx Not Tied to Retinal Vascular Occlusion

0

No increase seen in risk for occlusion of retinal artery, vein among women filling prescription for female hormone therapy

Fewer ER Visits for Asthma Crises After Obamacare: Study

Asthma EMS Dispatch Rate Down With Insurance Expansion

0

Asthma EMS dispatch rate in New York City decreased after implementation of the Affordable Care Act

Lack of Insurance Tied to Non-Rx Hormone Use in Transgender Adults

0

Authors say insurance barrier poses risks to safety, health, and well-being

HealthDay Reports: Most Americans

Major U.S. Medical Groups Urge Trump to Work With Biden on Fighting COVID-19

0

In letter from three medical associations, the president is urged 'to share critical data and information as soon as possible'

Pfizer COVID-19  Vaccine Reaches 90 Percent Effectiveness in Early Analysis

Moderna Vaccine Shows 94.5 Percent Effectiveness Against COVID-19

0

Company expects to have about 20 million doses of the vaccine ready to ship in the U.S. by the end of the year